Skip to Content

Biologist - Gene Therapy and T-cell Immunology

Oak Ridge Institute for Science and Education (ORISE) , Silver Spring, Maryland

Position Description:

*Applications will be reviewed on a rolling-basis.

A research opportunity is currently available with the Office of Tissues and Advanced Therapies (OTAT), at the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA) located in Silver Spring, Maryland.

The ORISE Research Participation Program at the U.S. Food and Drug Administration is an educational and training program designed to provide college students, recent graduates, and university faculty opportunities to connect with the unique resources of the FDA. With the support of an assigned mentor, participants have authentic hands-on research experience and allows them access to unique research opportunities, top scientists and engineers, and state-of the art facilities and equipment. The Center for Biologics Evaluation and Research (CBER) is one Center within the Food and Drug Administration, an Agency within the United States Government's Department of Health and Human Services. CBER's mission is to protect and enhance the public health through the regulation of biological and related products including blood, vaccines, allergenics, tissues, and cellular and gene therapies.

Under the guidance of a mentor, the selected participant will perform FDA/OTAT mission relevant laboratory research on gene therapy with focus on CAR-T cells. The participant will characterize intracellular signaling pathways of engineered T cells and assess novel product attributes to predict safety and efficacy of T cell therapies.

Anticipated Appointment Start Date: March 2021

This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for one year, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at FDA in the Silver Spring, Maryland, area. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.

Qualifications:

The qualified candidate should have received a doctoral degree in Basic Biomedical Sciences, Biology, Cellular and Molecular Biology, Immunology, Microbiology, or Virology. Degree must have been received within five years of the appointment start date.

Preferred skills:
  • Experience in gene therapy and T cell immunology, in particular, CAR-T cells
  • Strong collaborative skills
  • Excellent written and oral communication skills

To Apply:

Apply at: https://www.zintellect.com/Opportunity/Details/FDA-CBER-2021-0009

A complete application consists of:
  • An application
  • Transcript(s) – For this opportunity, an unofficial transcript or copy of the student academic records printed by the applicant or by academic advisors from internal institution systems may be submitted. All transcripts must be in English or include an official English translation. Click here for detailed information about acceptable transcripts.
  • A current resume/CV, including academic history, employment history, relevant experiences, and publication list
  • One educational or professional recommendation


All documents must be in English or include an official English translation.

If you have questions, send an email to ORISE.FDA.CBER@orau.org. Please include the reference code for this opportunity (FDA-CBER-2021-0009) in your email.

Application Deadline: March 29, 2021 3:00PM EST

 

The NIH is dedicated to building a diverse community in its training and employment programs.